Augmented expression of metallothionein and glutathione S-transferase pi as unfavourable prognostic factors in cisplatin-treated ovarian cancer patients

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Virchows Archiv

• Publication date

  2005-06-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00428-005-1228-0PMID 15968547
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic significance of mutant p53 protein, P-glycoprotein and glutathione S-transferase-pi in patients with unresectable non-small cell lung cancer.

  2003cited by this paper
• Multivariate analysis for prognostic significance of histologic subtype, GST‐pi, MDR‐1, and p53 in stages II‐IV ovarian cancer

  2003cited by this paper
• Prognostic significance of metallothionein expression in correlation with Ki-67 expression in adenocarcinomas of large intestine.

  2003cited by this paper
• Kinetic study on the reaction of cisplatin with metallothionein.

  2003cited by this paper
• Molecular determinants of treatment response in human germ cell tumors.

  2003cited by this paper
• Cisplatin: mode of cytotoxic action and molecular basis of resistance

  2003cited by this paper
• Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors.

  2003cited by this paper
• DNA ploidy assessment method applied to primary breast carcinoma FNA biopsies.

  2002cited by this paper
• Immunocytochemical evaluation of metallothionein (MT) expression in myoepithelial cells of ductal mammary carcinoma and its relation to survival time: analysis of 7-year course of the disease.

  2002cited by this paper
• Significance of Nuclear Glutathione S‐Transferase π in Resistance to Anti‐cancer Drugs

  2002cited by this paper
• Mechanisms of resistance to cisplatin.

  2001cited by this paper
• Immunohistochemical localization of metallothionein in benign and malignant epithelial ovarian tumors

  2001cited by this paper
• Expression of glutathione S-transferase pi (GST-pi) in human malignant ovarian tumors.

  2001cited by this paper
• Metallothionein expression in epithelial ovarian cancer: effect of chemotherapy and prognostic significance

  2000cited by this paper
• Metallothionein immunoreactivity in head and neck carcinomas; special reference to clinical behaviors and chemotherapy responses.

  2000cited by this paper
• Immunohistochemical analysis of drug resistance-associated proteins in ovarian carcinomas.

  2000cited by this paper
• Role of metallothionein in cisplatin sensitivity of germ‐cell tumours

  2000cited by this paper
• HeLa Cell Transformants Overproducing Mouse Metallothionein Show in vivo Resistance to cis‐Platinum in Nude Mice

  2000cited by this paper
• Ovarian cancer: epidemiology, biology, and prognostic factors.

  2000cited by this paper
• Metallothionein expression correlates with metastatic and proliferative potential in squamous cell carcinoma of the oesophagus

  1999cited by this paper
• Cisplatin-resistant bladder carcinoma cells: enhanced expression of metallothioneins

  1999cited by this paper
• Tumor response to neoadjuvant chemotherapy correlates with the expression of P-glycoprotein and PCNA but not GST-pi in the tumor cells of cervical carcinoma.

  1998cited by this paper
• TNM Classification of Malignant Tumors

  1998cited by this paper
• The prognostic role of p53, metallothionein, P-glycoprotein, and MIB-1 in muscle-invasive urothelial transitional cell carcinoma.

  1998cited by this paper
• Toward the development of a universal grading system for ovarian epithelial carcinoma

  1998cited by this paper
• Overexpression of metallothionein correlates with chemoresistance to cisplatin and prognosis in esophageal cancer.

  1997cited by this paper
• Immunohistochemical staining for glutathione S-transferase predicts response to platinum-based chemotherapy in head and neck cancer.

  1996cited by this paper
• Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas.

  1995cited by this paper
• National survey of ovarian carcinoma. I. A patient care evaluation study of the American College of Surgeons.

  1993cited by this paper
• Overview of metallothionein.

  1991cited by this paper
• Overexpressed human metallothionein IIA gene protects Chinese hamster ovary cells from killing by alkylating agents.

  1990cited by this paper
• [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue].

  1987cited by this paper
• Metallothionein.

  1986cited by this paper

• Stemness and EMT profiles shift in xenografts derived from cisplatin-sensitive and cisplatin-tolerant ovarian cancer cells

  2026cites this paper
• Unraveling the role of deubiquitinating enzymes on cisplatin resistance in several cancers.

  2025cites this paper
• A Novel Approach to Overcome Cisplatin Resistance in Ovarian Cancer: Revealing the Synergistic Potential of Quercetin-Loaded Solid Lipid Nanoparticles

  2025cites this paper
• Redox Biomarkers and Matrix Remodeling Molecules in Ovarian Cancer

  2024cites this paper
• Resistance to the platinum‑based chemotherapeutic drugs in oral cancer: Focus on the role of p22phox (Review)

  2024cites this paper
• Deciphering the Molecular Mechanisms behind Drug Resistance in Ovarian Cancer to Unlock Efficient Treatment Options

  2024cites this paper
• Role of microRNAs in regulation of doxorubicin and paclitaxel responses in lung tumor cells

  2023cites this paper
• An Assessment of MT1A (rs11076161), MT2A (rs28366003) and MT1L (rs10636) Gene Polymorphisms and MT2 Concentration in Women with Endometrial Pathologies

  2023cites this paper
• Effect of Tamoxifen on Proteome Expression during In Vitro Myogenesis in Murine Skeletal Muscle C2C12 Cells

  2023cites this paper
• Therapeutic strategies to overcome cisplatin resistance in ovarian cancer.

  2022cites this paper
• Fyn expression is associated with the response of patients with locally advanced uterine cervical squamous cell carcinoma to neoadjuvant chemotherapy

  2022cites this paper
• The Profile of MicroRNA Expression and Potential Role in the Regulation of Drug-Resistant Genes in Cisplatin- and Paclitaxel-Resistant Ovarian Cancer Cell Lines

  2022cites this paper
• Upregulation of the Long Noncoding RNA CASC10 Promotes Cisplatin Resistance in High-Grade Serous Ovarian Cancer

  2022cites this paper
• The molecular and cellular basis of copper dysregulation and its relationship with human pathologies

  2021cites this paper
• Cisplatin Resistance in Ovarian Cancer: Classical Outlook and Newer Perspectives

  2021cites this paper
• Gene Signatures Induced by Ionizing Radiation as Prognostic Tools in an In Vitro Experimental Breast Cancer Model

  2021cites this paper
• T-box 2 expression is a useful indicator of the response to neoadjuvant chemotherapy for patients with locally advanced uterine cervical squamous cell carcinoma

  2021cites this paper
• Metal- and metalloid-based compounds to target and reverse cancer multidrug resistance.

  2021cites this paper
• Models for measuring metabolic chemical changes in the metastasis of high grade serous ovarian cancer: fallopian tube, ovary, and omentum.

  2021cites this paper
• Metallothionein isoforms as double agents - Their roles in carcinogenesis, cancer progression and chemoresistance.

  2020cites this paper
• Burgeoning Polymer Nano Blends for Improved Controlled Drug Release: A Review

  2020cites this paper
• Interested in publishing with us ? Contact book

  2019cites this paper
• Phosphorylation of STAT1 serine 727 enhances platinum resistance in uterine serous carcinoma

  2019cites this paper
• New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment

  2019cites this paper
• Non-Traditional Metallation of Metallothioneins with Xenobiotic Therapeutic Metals

  2019cites this paper
• Oral Cancer

  2019cites this paper
• Nickel-induced global gene expressions in red maple ( Acer rubrum ): Effect of nickel concentrations

  2018cites this paper
• The roles of metallothioneins in carcinogenesis

  2018cites this paper
• A Prisma-compliant meta-analysis

  2018cites this paper
• Metallothionein: An Aggressive Scavenger—The Metabolism of Rhodium(II) Tetraacetate (Rh2(CH3CO2)4)

  2018cites this paper
• Glutathione in Ovarian Cancer: A Double-Edged Sword

  2018cites this paper
• Adverse drug reactions and kinetics of cisplatin excretion in urine of patients undergoing cisplatin chemotherapy and radiotherapy for head and neck cancer: a prospective study

  2017cites this paper
• A Retrospective Study of Equine Liver Lesions in Western Canada and the Expression of Metallothionein by Immunohistochemistry

  2017cites this paper
• The role of Nrf2 and ATF2 in resistance to platinum-based chemotherapy

  2017cites this paper
• Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell lines

  2017influential citation
• New and Old Genes Associated with Primary and Established Responses to Cisplatin and Topotecan Treatment in Ovarian Cancer Cell Lines

  2017cites this paper
• Soluble CD40 ligands sensitize the epithelial ovarian cancer cells to cisplatin treatment.

  2016cites this paper
• The timing of caffeic acid treatment with cisplatin determines sensitization or resistance of ovarian carcinoma cell lines

  2016cites this paper
• Cisplatin resistance and opportunities for precision medicine.

  2016cites this paper
• Basal and copper-induced expression of metallothionein isoform 1,2 and 3 genes in epithelial cancer cells: The role of tumor suppressor p53.

  2016cites this paper
• Effect of miR-155 knockdown on the reversal of doxorubicin resistance in human lung cancer A549/dox cells.

  2016cites this paper
• Metallothionein and cancer

  2015cites this paper
• Interactions of cisplatin with non-DNA targets and their influence on anticancer activity and drug toxicity: the complex world of the platinum complex.

  2015cites this paper
• ResearchUp-regulation of fas reverses cisplatin resistance of human small cell lung cancer cells

  2015cites this paper
• The role and mechanism of WEE1 on the cisplatin resistance reversal of the HepG2/DDP human hepatic cancer cell line.

  2015cites this paper
• CATIONIC PEPTIDE LACTOFERRICIN B INHIBITS GLUTATHIONE S-TRANSFERASE P1 FROM HUMAN PLACENTA AND BREAST CANCER CELL LINE MDA-MB-231 PREVENTING ANTICANCER DRUG METABOLISM

  2015cites this paper
• The role and mechanism of WEE 1 on the cisplatin resistance reversal of the HepG 2 / DDP human hepatic cancer cell line

  2015cites this paper
• Chronically sun-damaged melanomas express low levels of nuclear glutathione-S-transferase-π: an epidemiological and clinicopathological study in Italy.

  2015cites this paper
• Metallothioneins in the lung cancer.

  2015cites this paper
• Collateral sensitivity to cisplatin in KB-8-5-11 drug-resistant cancer cells.

  2014cites this paper
• Metallothionein 3 Expression in Normal Skin and Malignant Skin Lesions

  2014cites this paper
• Sensitization of mesothelioma cells to platinum-based chemotherapy by GSTπ knockdown.

  2014cites this paper
• Overview of a chemoresponse assay in ovarian cancer

  2014cites this paper
• Metallothionein – Immunohistochemical Cancer Biomarker: A Meta-Analysis

  2014cites this paper
• Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines

  2014cites this paper
• Measuring DNA damage and associated epigenetic changes genome-wide in cells following exposure to platinum analogue chemotherapeutic drugs

  2014cites this paper
• Effect of the human serum albumin concentration on the metabolism of cisplatin in vitro

  2014cites this paper
• Identification and Characterization of a Stem Cell-Like Population in Ovarian Cancer

  2014cites this paper
• In vitro analysis of the relationships between metallothionein expression and cisplatin sensitivity of non-small cellular lung cancer cells.

  2013cites this paper
• Quercetin inhibits proliferation and increases sensitivity of ovarian cancer cells to cisplatin and paclitaxel.

  2013cites this paper
• CİSPLATİN DİRENCİNDE ETKİLİ MOLEKÜLER MEKANİZMALAR

  2013cites this paper
• Prognostic significance of several biomarkers in epithelial ovarian cancer: a meta-analysis of published studies

  2013cites this paper
• Glutathione S‐transferase P1 single nucleotide polymorphism predicts permanent ototoxicity in children with medulloblastoma

  2013cites this paper
• Retained platinum uptake and indifference to p53 status make novel transplatinum agents active in platinum-resistant cells compared to cisplatin and oxaliplatin

  2012cites this paper
• Immunohistochemistry with apoptotic-antiapoptotic proteins (p53, p21, bax, bcl-2), c-kit, telomerase, and metallothionein as a diagnostic aid in benign, borderline, and malignant serous and mucinous ovarian tumors

  2012cites this paper
• Expression of Metallothionein in Oral Cancer

  2012cites this paper
• Therapeutic radiation induces different changes in expression profiles of metallothionein (MT) mRNA, MT protein, Ki 67 and minichromosome maintenance protein 3 in human rectal adenocarcinoma.

  2012cites this paper
• MGST1 expression in serous ovarian carcinoma differs at various anatomic sites, but is unrelated to chemoresistance or survival.

  2012cites this paper
• Role of metallothioneins in benign and malignant thyroid lesions

  2012cites this paper
• Pharmacologie des cytotoxiques antitumoraux

  2011cites this paper
• Mitigating cisplatin resistance in ovarian cancer.

  2011cites this paper
• Anticancer Activity of Metal Complexes: Involvement of Redox Processes

  2011cites this paper
• Researchof fas reverses cisplatin resistance of human small cell lung cancer cells

  2010cites this paper
• Metallothionein and Metal Homeostasis

  2010cites this paper
• Automated Electrochemical Analyzer as a New Tool for Detection of Thiols

  2010cites this paper
• The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin

  2010cites this paper
• Redox protein expression predicts progression-free and overall survival in ovarian cancer patients treated with platinum-based chemotherapy.

  2010cites this paper
• Up-regulation of fas reverses cisplatin resistance of human small cell lung cancer cells

  2010cites this paper
• Identification and characterization of a spontaneous ovarian carcinoma in Lewis rats

  2010cites this paper
• Intensification thérapeutique dans les cancers colorectaux par des études pharmacogénétiques et pharmacogénomiques

  2010cites this paper
• Metallothioneins and cancer.

  2009cites this paper
• Metallothionein-overexpression as a prognostic marker in melanoma.

  2009cites this paper
• Epigenetic Alteration of the Metallothionein 1E Gene in Human Endometrial Carcinomas

  2009cites this paper
• The role of metallothionein in oncogenesis and cancer prognosis.

  2009cites this paper
• DNA damage induced by cis- and carboplatin as indicator for in vitro sensitivity of ovarian carcinoma cells

  2009cites this paper
• Comparison of Metallothionein Detection by Using Brdicka Reaction and Enzyme‐Linked Immunosorbent Assay Employing Chicken Yolk Antibodies

  2009cites this paper
• An overview of the relations between polymorphisms in drug metabolising enzymes and drug transporters and survival after cancer drug treatment.

  2009cites this paper
• BCNU-sequestration by metallothioneins may contribute to resistance in a medulloblastoma cell line

  2009cites this paper
• The thioredoxin system: a key target in tumour and endothelial cells.

  2008cites this paper
• Employment of Electrochemical Techniques for Metallothionein Determination in Tumor Cell Lines and Patients with a Tumor Disease

  2008cites this paper
• Utilizing of Adsorptive Transfer Stripping Technique Brdicka Reaction for Determination of Metallothioneins Level in Melanoma Cells, Blood Serum and Tissues

  2008cites this paper
• Resistance to Chemotherapy in Cancer: A Complex and Integrated Cellular Response

  2008cites this paper
• Pharmacogenetics and Pharmacokinetics in high-dose alkylating chemotherapy

  2008cites this paper
• Molecular mechanisms of resistance and toxicity associated with platinating agents.

  2007cites this paper
• The role of glutathione-S-transferase polymorphisms in ovarian cancer survival.

  2007cites this paper
• Mechanismen der Chemotherapieresistenz beim Ovarialkarzinom

  2007cites this paper
• Les dérivés du platine

  2007cites this paper
• Comparison of metallothionein‐overexpression with sentinel lymph node biopsy as prognostic factors in melanoma

  2007cites this paper
• Resistance to chemotherapy in ovarian carcinoma.

  2007cites this paper
• Metallothionein overexpression, a highly significant prognostic factor in thin melanoma

  2007cites this paper